Patent classifications
C07D277/593
MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
HISTONE DEACETYLASE INHIBITORS
This invention relates to generally inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
HISTONE DEACETYLASE INHIBITORS
This invention relates to generally inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF
In one aspect, an active agent-conjugate, methods of preparing the active agent-conjugate, and uses thereof is provided.
DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF
In one aspect, an active agent-conjugate, methods of preparing the active agent-conjugate, and uses thereof is provided.
Histone deacetylase inhibitors
This invention relates to generally inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
Histone deacetylase inhibitors
This invention relates to generally inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
Drug-conjugates, conjugation methods, and uses thereof
In one aspect, an active agent-conjugate, methods of preparing the active agent-conjugate, and uses thereof is provided.
Drug-conjugates, conjugation methods, and uses thereof
In one aspect, an active agent-conjugate, methods of preparing the active agent-conjugate, and uses thereof is provided.
Drug-conjugates, conjugation methods, and uses thereof
In one aspect, an active agent-conjugate, methods of preparing the active agent-conjugate, and uses thereof is provided.